BABY up +2.75% percent right now. $BABY High is at 34.18

New Post Public Reply Private Reply Replies (0) Message Board

Nov 10, 2014 at 3:09 PM

BABY up +2.75% percent right now. $BABY High is at 34.18 and the Low 33.00 with current volume of 137,683.

Recent News posted below.

BABY Natus Medical Inc Recent Headline News

Natus Medical Has Returned 29.9% Since SmarTrend Recommendation (BABY)
Comtex SmarTrend(R) - Thu Nov 06, 9:12AM CST
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 7 months, Natus Medical has returned 29.90% as of today's recent price of $33.89.
BABY: 34.25 (+1.10)

Sleep Apnea Diagnostic and Therapeutic Devices - 2014 Global Strategic Business Report
M2 - Thu Oct 30, 6:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbnnd7/sleep_apnea) has announced the addition of the "Sleep Apnea Diagnostic and Therapeutic Devices - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as: - Cadwell Laboratories, Inc. - CareFusion Corporation - Cleveland Medical Devices, Inc. - Compumedics Ltd. - DeVilbiss Healthcare - Global Medical Holdings LLC - Fisher & Paykel Healthcare Limited - GE Healthcare - Itamar Medical Ltd. - Invacare Corporation - Natus Medical Inc. - Embla Systems, Inc. - Grass Technologies - Philips Healthcare - ResMed Inc. - Teleflex Medical - Weinmann Ger?te f?r Medizin GmbH CCo. KG Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Market Overview 2. Market Trends And Dynamics 3. Sleep Apnea - A Synopsis 4. Sleep Apnea Diagnostic And Therapeutic Devices 5. Research Findings In Recent Past 6. Product Launches/Introductions 7. Recent Industry Activity 8. Focus On Select Players 9. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Middle East And Africa IV. Competitive Landscape Total Companies Profiled: 71 (including Divisions/Subsidiaries - 76) - The United States (48) - Canada (4) - Japan (1) - Europe (12) - - Germany (3) - - The United Kingdom (2) - - Italy (2) - - Spain (2) - - Rest of Europe (3) - Asia-Pacific (Excluding Japan) ( - Middle East (3) For more information visit http://www.researchandmarkets.com/research/qb...leep_apnea
BABY: 34.25 (+1.10), IVC: 16.13 (+0.33), RMD: 50.94 (-0.20)

Shares of BABY Up 28.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 29, 4:49PM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 28.94% as of today's recent price of $33.64.
BABY: 34.25 (+1.10)

Edwards Lifesciences (EW) Worth Watching: Stock Up 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:25AM CDT
Edwards Lifesciences (EW) was a big mover last session, with shares rising 11% on the day.
BABY: 34.25 (+1.10), PACB: 6.64 (+0.12), EW: 124.31 (+1.55), ANGO: 16.95 (unch)

Is Natus Medical (BABY) a Great Growth Stock? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:53AM CDT
If you are looking for a fast growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Natus Medical.
BABY: 34.25 (+1.10)

3 Momentum Stocks to Watch in Biotechnology for Continued Upside
at The Street - Thu Oct 23, 2:39PM CDT
Wednesday was a strong session for a number of stocks, and here are three, in particular, to watch for more upside.
BABY: 34.25 (+1.10), RGLS: 21.65 (-0.43), AGIO: 80.54 (+8.48)

Natus Medical Rises 1.71% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Wed Oct 22, 5:38PM CDT
Natus Medical (NASDAQ:BABY) traded in a range yesterday that spanned from a low of $31.06 to a high of $33.20. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $32.44 on volume of 863,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BABY: 34.25 (+1.10)

Natus Medical's (BABY) CEO Jim Hawkins on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Oct 22, 1:57PM CDT

BABY: 34.25 (+1.10)

Natus Medical Inc. Hears Higher Margins Calling
Brian Orelli, The Motley Fool - Motley Fool - Wed Oct 22, 1:53PM CDT
Organic revenue growth of 5% is nothing to get too excited about, but increasing margins made for a nice bottom-line improvement at Natus Medical . Non-GAAP net income increased 16.5% year over year in the third quarter to $10.6 million. Gross...
BABY: 34.25 (+1.10)

Natus Medical Shares Up 19.4% Since SmarTrend's Buy Recommendation (BABY)
Comtex SmarTrend(R) - Wed Oct 22, 11:05AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 19.39% as of today's recent price of $31.15.
BABY: 34.25 (+1.10)

Natus Medical Incorporated (BABY) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Wed Oct 22, 9:55AM CDT

BABY: 34.25 (+1.10)

Natus Medical raises guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 8:29AM CDT

BABY: 34.25 (+1.10)

Natus Medical tops Street 3Q forecasts
Automated Insights - Wed Oct 22, 6:57AM CDT
SAN CARLOS, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported earnings of $7.8 million in its third quarter.
BABY: 34.25 (+1.10)

Natus Medical beats by $0.02, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 6:15AM CDT

BABY: 34.24 (+1.09)

Natus Medical Announces Record Third Quarter and Year-to-Date 2014 Financial Results
GlobeNewswire - Wed Oct 22, 6:04AM CDT
-- Reports organic revenue growth of 5% for the third quarter
BABY: 34.25 (+1.10)

Don't Miss Today's Strong And Under The Radar Stock: Natus Medical (BABY)
at The Street - Tue Oct 21, 8:51AM CDT
Trade-Ideas LLC identified Natus Medical (BABY) as a strong and under the radar candidate
BABY: 34.25 (+1.10)

Natus Medical Announces First of Kind Vista Ultrasound System
GlobeNewswire - Thu Oct 16, 6:00AM CDT
Natus Medical Incorporated (Nasdaq:BABY) today announced the launch of the Vista Ultrasound System. The Vista Ultrasound System is the first product in the market to enable the use of Ultrasound with an EMG workstation. The Vista Ultrasound System adds ultrasound capability to Natus' market leading EDX and UltraPro S100 EMG workstations. The new Vista Ultrasound System will be available worldwide.
BABY: 34.25 (+1.10)

Shares of BABY Up 14.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Oct 15, 9:53AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 14.67% as of today's recent price of $29.92.
BABY: 34.25 (+1.10)

4 Stocks Rising on Big Volume to Trade for Breakouts
at The Street - Mon Oct 13, 6:53AM CDT
These stocks rising on unusual volume are within range of triggering breakout trades.
ZUMZ: 33.86 (-1.24), ECOL: 44.17 (-2.84), BABY: 34.25 (+1.10), ANGO: 16.95 (unch)

Natus Medical Up 17.2% Since SmarTrend Uptrend Call (BABY)
Comtex SmarTrend(R) - Wed Oct 08, 9:18AM CDT
SmarTrend identified an Uptrend for Natus Medical (NASDAQ:BABY) on April 24th, 2014 at $26.09. In approximately 6 months, Natus Medical has returned 17.25% as of today's recent price of $30.59.
BABY: 34.25 (+1.10)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

CapCut's Role in AI-Assisted Small Biz Marketing

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...